Legend Biotech (LEGN) Current Leases (2019 - 2025)

Legend Biotech has reported Current Leases for 7 years, with the latest figure at $7.4 million in Q4 2025.

• For the quarter ending Q4 2025, Current Leases rose 54.17% year-over-year to $7.4 million; the trailing twelve-month figure through Dec 2025 stood at $7.4 million (up 54.17% YoY), and the FY2025 full-year result was $7.4 million, up 54.17% from the prior year.
• Current Leases for Q4 2025 stood at $7.4 million, roughly flat from $7.4 million in the prior quarter.
• The five-year high for Current Leases was $7.4 million in Q4 2025, with the low at $1673.0 in Q1 2021.
• Historically, Current Leases has averaged $3.7 million across 5 years, with a median of $3.6 million in 2022.
• Annual changes were most pronounced in 2021 — Current Leases slumped 37.77% — and 2022, when it jumped 218070.95%.
• Legend Biotech's Current Leases stood at $911000.0 in 2021, then surged by 291.11% to $3.6 million in 2022, then retreated by 10.89% to $3.2 million in 2023, then surged by 51.18% to $4.8 million in 2024, then surged by 54.17% to $7.4 million in 2025.
• The last three Current Leases figures came in at $7.4 million (Q4 2025), $7.4 million (Q3 2025), and $5.9 million (Q2 2025), per Business Quant data.